The effect of green coffee supplementation on patients with polycystic ovary syndrome

The effect of green coffee supplementation on androgens levels in patients with polycystic ovary syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180711040428N1

Enrollment

Registered

2018-10-15

Start date

2018-07-22

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrom. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: The blood samples are taken prior to the intervention and the serum is isolated. Then, the level of androgens and lipid and sugar determinants is measured by ELISA

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Having polycystic ovarian syndrome Age group between 20 and 40 years old Use of pcos syndrome drugs Body mass index from 18.5 to 39.9

Exclusion criteria

Exclusion criteria: The desire to get pregnant while studying Being pregnant Thyroid and renal failure Consuming food supplements Coffee susceptibility Acute abnormalities in women with polycystic ovary syndrome during the research period

Design outcomes

Primary

Measure	Time frame
Androgens. Timepoint: Before starting the study and 60 days after taking the green coffee pill. Method of measurement: Elisa device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad saedi

Islamic Azad University

Ahmadmousavi7772@gmail.com+98 21 4486 5154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026